Login / Signup
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer.
Di Zhang
Lixi Li
Zongbi Yi
Published in:
Cancer innovation (2024)
Gap junction beta-2 may be a promising therapeutic target for targeted therapy and immunotherapy and may be used to predict breast cancer prognosis.
Keyphrases
</>
breast cancer risk
young adults